Sunday, August 31, 2014 4:59:16 PM
Depends on the situation if it's appropriate or not but in this case despite Marco's tendency to exaggerate it's the truth.
It DOES give him a unique ability to mix formulates for commercial use. What he's doing now is another story, but he has the potential and so does DEWMAR International, to do much bigger things.
He knows the business end has not been his strong suit and has been attending conferences and so on, working on it.
I"m not pumping so don't even go there, just sayin' we are uniquely positioned in the broader marketplace, IF Marco and his new mentor Perlowin of HEMP can exploit it -- and not exploit us. So far I'm willing to believe they have to be mum for legal reasons, negotiations goin' on... optimistic yet weary as we Wait for Godot.
Happy Labor Day Y'all!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM